Tokyo Tape
Sign in
← BrightPath Biotherapeutics

Annual report

4594.TEDINET S100QKJ2
Period2022-04-01 → 2023-03-31
Filed2023-06-22
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 78
MetricValuePeriodScopeSource row
Revenue¥5m2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥15m2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥3m2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥11m2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥156m2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Operating income−¥1.5bn2022-04-01 → 2023-03-31StandaloneOperating income
Operating income−¥1.5bn2021-04-01 → 2022-03-31StandaloneOperating income
Ordinary income−¥1.5bn2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income−¥1.5bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income−¥1.7bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.8bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.7bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.5bn2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Profit before tax−¥1.5bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Net income−¥1.5bn2022-04-01 → 2023-03-31StandaloneProfit loss
Net income−¥1.5bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income−¥1.7bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income−¥1.9bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income−¥1.9bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Total assets¥1.7bnat 2023-03-31StandaloneAssets
Total assets¥2.8bnat 2022-03-31StandaloneAssets
Total assets¥3.7bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥3.5bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥5.3bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥134mat 2023-03-31StandaloneLiabilities
Total liabilities¥240mat 2022-03-31StandaloneLiabilities
Net assets / equity¥1.6bnat 2023-03-31StandaloneNet assets
Net assets / equity¥2.5bnat 2022-03-31StandaloneNet assets
Net assets / equity¥3.5bnat 2021-03-31dStandaloneNet assets
Net assets / equity¥3.2bnat 2020-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥5.1bnat 2019-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥1.5bnat 2023-03-31StandaloneCash and deposits
Cash and deposits¥2.3bnat 2022-03-31StandaloneCash and deposits
Cash & equivalents¥1.5bnat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥2.3bnat 2022-03-31StandaloneCash and cash equivalents
Cash & equivalents¥3.3bnat 2021-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥3.0bnat 2020-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥4.9bnat 2019-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.2bn2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.5bn2021-04-01 → 2022-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.8bn2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.8bn2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.5bn2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥2m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥18m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥36m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥107m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥185m2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥432m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥569m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥2.1bn2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥9m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥16m2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-24.92022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-28.552021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.142020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-44.22019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-44.952018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥24.6at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥45.4at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥69.1at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥75.49at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥119.66at 2019-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio90.9%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.5%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio93.7%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio91.5%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio94.7%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued62,891,200at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued55,253,100at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued50,817,500at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued42,101,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued41,993,500at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees32at 2023-03-31StandaloneNumber of employees
Employees38at 2022-03-31StandaloneNumber of employees
Employees44at 2021-03-31dStandaloneNumber of employees
Employees44at 2020-03-31dStandaloneNumber of employees
Employees42at 2019-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 759
ItemContextValueUnit
Capital surplusCurrentYearInstant_NonConsolidatedMember2670720000JPY
Retained earnings brought forwardPrior1YearInstant_NonConsolidatedMember-10875815000JPY
Retained earnings brought forwardCurrentYearInstant_NonConsolidatedMember-1485633000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember-10875815000JPY
Retained earningsCurrentYearInstant_NonConsolidatedMember-1485633000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember－JPY
Treasury stockCurrentYearInstant_NonConsolidatedMember-0JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember2508534000JPY
Shareholders equityCurrentYearInstant_NonConsolidatedMember1547272000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember22940000JPY
Subscription rights to sharesCurrentYearInstant_NonConsolidatedMember20268000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember2531475000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember1567541000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember2771202000JPY
Liabilities and net assetsCurrentYearInstant_NonConsolidatedMember1701444000JPY
Net salesPrior1YearDuration_NonConsolidatedMember15408000JPY
Net salesCurrentYearDuration_NonConsolidatedMember5280000JPY
Research and development costsPrior1YearDuration_NonConsolidatedMember102000JPY
Research and development costsCurrentYearDuration_NonConsolidatedMember70000JPY
Cost of other sales cosPrior1YearDuration_NonConsolidatedMember3215000JPY
Cost of other sales cosCurrentYearDuration_NonConsolidatedMember1825000JPY
Cost of salesPrior1YearDuration_NonConsolidatedMember3317000JPY
Cost of salesCurrentYearDuration_NonConsolidatedMember1895000JPY
Gross profitPrior1YearDuration_NonConsolidatedMember12091000JPY
Gross profitCurrentYearDuration_NonConsolidatedMember3384000JPY
Selling general and administrative expensesPrior1YearDuration_NonConsolidatedMember1488124000JPY
Selling general and administrative expensesCurrentYearDuration_NonConsolidatedMember1470443000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember-1476033000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember-1467059000JPY
Interest income noiPrior1YearDuration_NonConsolidatedMember27000JPY
Interest income noiCurrentYearDuration_NonConsolidatedMember20000JPY
Other noiPrior1YearDuration_NonConsolidatedMember89000JPY
Other noiCurrentYearDuration_NonConsolidatedMember546000JPY
Non operating incomePrior1YearDuration_NonConsolidatedMember117000JPY
Non operating incomeCurrentYearDuration_NonConsolidatedMember567000JPY
Interest on bonds noePrior1YearDuration_NonConsolidatedMember362000JPY
Interest on bonds noeCurrentYearDuration_NonConsolidatedMember61000JPY
Foreign exchange losses noePrior1YearDuration_NonConsolidatedMember3470000JPY
Foreign exchange losses noeCurrentYearDuration_NonConsolidatedMember4822000JPY
Stock issuance cost noePrior1YearDuration_NonConsolidatedMember2197000JPY
Stock issuance cost noeCurrentYearDuration_NonConsolidatedMember2094000JPY
Other noePrior1YearDuration_NonConsolidatedMember－JPY
Other noeCurrentYearDuration_NonConsolidatedMember305000JPY
Non operating expensesPrior1YearDuration_NonConsolidatedMember6029000JPY
Non operating expensesCurrentYearDuration_NonConsolidatedMember7283000JPY
Ordinary incomePrior1YearDuration_NonConsolidatedMember-1481945000JPY
Ordinary incomeCurrentYearDuration_NonConsolidatedMember-1473774000JPY
Gain on reversal of subscription rights to shares eiPrior1YearDuration_NonConsolidatedMember5899000JPY
Gain on reversal of subscription rights to shares eiCurrentYearDuration_NonConsolidatedMember－JPY
Gain on sales of noncurrent assets eiPrior1YearDuration_NonConsolidatedMember13000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2022-03-31pass
balance sheet identitynon_consolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · operating cash flownon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass